Global Clinical Trial Software Market

$1,050.00

产品代码: GH04185I 行业: 地区:

Clinical trial software is a type of software designed specifically for the management and execution of clinical trials. Clinical trials are medical research studies in which human participants are involved to evaluate the effectiveness, 安全, and side effects of new drugs, 医疗设备, and treatments. Clinical trial software helps clinical research organizations and pharmaceutical companies to manage, track, and monitor all aspects of the clinical trial process, from recruiting participants and managing study data to monitoring adverse events and generating reports. Such software often contains modular functionalities that allow customized workflows and processes, depending on the requirements of the particular study. The analysis predicts the global clinical trial software market will grow from USD 1,061.0 百万 2022 兑美元 2,385.4 百万 2029, 实现复合年增长率 (复合年增长率) 的 12.27 百分.

该行业报告提供了全球市场的市场预测, followed by a detailed analysis of the feature, delivery, 最终用户, 和地区. The global market data on clinical trial software can be segmented by feature: EDC, eCOA & ePRO, econsent. The EDC segment was the largest contributor to the global clinical trial software market in 2022. Clinical trial software market is further segmented by delivery: 本地部署, SaaS, web-based. 据研究, the web-based segment had the largest share in the global clinical trial software market. 基于最终用户, the clinical trial software market is segmented into: biotech and pharmaceutical companies, 合同研究组织, 医疗器械公司, 其他的. The CROs segment held the largest revenue share in 2022. 根据地区, the clinical trial software market also can be divided into: 北美, 欧洲, 亚太, 事物 (中东和非洲), 拉美. 全球范围, North America made up the largest share of the clinical trial software market.

The global clinical trial software market is highly competitive. Key companies profiled in the report include BSI Business Systems Integration AG, Clario (combination of Bioclinica and ERT), Dassault Systemes SE, DATATRAK International Inc., Fortress Medical Systems LLC., IBM公司, IQVIA Holdings Inc., Laboratory Corp of America Holdings (LabCorp), Medrio Inc., OpenClinica LLC, 甲骨文公司, Parexel International Corporation, RealTime Software Solutions LLC, Reify Health Inc., Veeva Systems Inc.

以数据为中心的报告重点关注市场趋势, 各细分市场的现状和前景. 对主要地区进行全面的市场评估, 该报告对于现有参与者来说是宝贵的资产, 新进入者和未来投资者.

为什么购买这份报告?
• Get a detailed picture of the Global Clinical Trial Software Market
• Identify segments/areas to invest in over the forecast period in the Global Clinical Trial Software Market
• Understand the competitive environment, 市场的领先参与者
• 以 Excel 格式进行跨场景分析的市场预估.
• 三个月的战略咨询和研究支持.
• 为单用户许可证提供打印验证.

Global Clinical Trial Software Market

对这份报告感兴趣? 立即获取免费样品!
Global Clinical Trial Software Market - 报告范围
报告属性

细节

基准年

2022

预测年份

2023-2029

复合年增长率 (2023-2029)

12.27%

页数

24

行业参与者

BSI Business Systems Integration AG, Clario (combination of Bioclinica and ERT), Dassault Systemes SE, DATATRAK International Inc., Fortress Medical Systems LLC., IBM公司, IQVIA Holdings Inc., Laboratory Corp of America Holdings (LabCorp), Medrio Inc., OpenClinica LLC, 甲骨文公司, Parexel International Corporation, RealTime Software Solutions LLC, Reify Health Inc., Veeva Systems Inc.

相关报道
想要定制此报告?
本报告可以灵活地根据您的具体需求进行定制. 我们的分析师和行业专家团队将直接与您合作,全面了解您的需求.
滚动至顶部

下载免费样品 - Global Clinical Trial Software Market

请填写我们的表格,我们会尽快回复您.